Howell, S. J., Anderson, E., Hunter, T., Farnie, G., & Clarke, R. B. (2008). Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity. BioMed Central.
Citação norma ChicagoHowell, Sacha J., Elizabeth Anderson, Tom Hunter, Gillian Farnie, and Robert B. Clarke. Prolactin Receptor Antagonism Reduces the Clonogenic Capacity of Breast Cancer Cells and Potentiates Doxorubicin and Paclitaxel Cytotoxicity. BioMed Central, 2008.
MLA CitationHowell, Sacha J., et al. Prolactin Receptor Antagonism Reduces the Clonogenic Capacity of Breast Cancer Cells and Potentiates Doxorubicin and Paclitaxel Cytotoxicity. BioMed Central, 2008.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.